金威醫療集團有限公司 2023/2024 年報1 香港聯合交易所有限公司（「聯交所 」）gem之特色 gem乃為投資風險較其他於聯交所上市之公司為高之中小型公司提供上市之市場。有意投資之人士應了解投資於該等公司之潛在風險，並應經過審慎周詳之考慮後方作出投資決定。由於在gem上市之公司一般為中小型公司，在gem買賣之證券可能會較在聯交所主板買賣之證券承受較大之市場波動風險，同時無法保證在gem買賣之證券會有高流通量之市場。香港交易及結算所有限公司以及香港聯合交易所有限公司（「聯交所」）對本報告之內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本報告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。本報告乃根據聯交所gem證券上市規則（「gem上市規則」）提供有關金威醫療集團有限公司（「本公司」）之資料，本公司之各董事（「董事」）願就本報告之內容共同及個別承擔全部責任。各董事在作出一切合理查詢後確認，據彼等所深知及確信，本報告所載之資料於各重大方面均屬準確完整，且無誤導或欺騙成分，而本報告亦無遺漏其他事項，以致本報告所載任何陳述或本報告有所誤導。characteristics of gem of the stock exchange of hong kong limited (the “stock exchange”)gem has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the stock exchange. prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after due and careful consideration.given that the companies listed on gem are generally small and mid-sized companies, there is a risk that securities traded on gem may be more susceptible to high market volatility than securities traded on the main board of the stock exchange and no assurance is given that there will be a liquid market in the securities traded on gem.hong kong exchanges and clearing limited and the stock exchange of hong kong limited (the “stock exchange”)take no responsibility for the contents of this report, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this report.this report, for which the directors (the “directors”) of good fellow healthcare holdings limited (the “company”) collectively and individually accept full responsibility, includes particulars given in compliance with the rules governing the listing of securities on gem of the stock exchange (the “gem listing rules”) for the purpose of giving information with regard to the company. the directors, having made all reasonable enquiries, confirm that, to the best of their knowledge and belief the information contained in this report is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this report misleading. good fellow healthcare holdings limited annual report 2023/20242contents目 錄 # 本報告內載入之中文名稱或詞語之英文譯名（如有指示）僅供參考之用，而不應視為有關中文名稱及詞語之官方英文譯名。為僅供說明之用，本報告內以人民幣計值的金額乃按人民幣1.00元兌1.083港元之匯率換算為港元，惟該換算不應視為表示有關金額已經、可能已經或可以任何特定匯率進行換算。corporate information 3公司資料chairman’s statement 6主席報告management discussion and analysis 8管理層討論及分析directors’ and senior management’s profiles 25董事及高級管理人員簡歷corporate governance report28企業管治報告report of the directors 46董事會報告independent auditors’ report 62獨立核數師報告consolidated statement of profit or loss and other comprehensive income 70綜合損益及其他全面收益表consolidated statement of financial position 72綜合財務狀況表consolidated statement of changes in equity 74綜合權益變動表consolidated statement of cash flows 76綜合現金流量表notes to the consolidated financial statements 78綜合財務報表附註financial summary 192財務摘要# the english translation of chinese names or words in this report, where indicated, is included for information purpose only, and should not be regarded as the official english translation of such chinese names and words.for the purposes of illustration only, amounts denominated in rmb in this report have been translated into hk$ at the rate of rmb1.00 = hk$1.083. such translation should not be constructed as a representation that the amounts in question have been, could have been or could be converted at any particular rate at all.contents目 錄 金威醫療集團有限公司 2023/2024 年報3corporate information公司資料 執行董事吳志龍（主席）鄭鋼（自二零二三年八月二十二日起辭任）吳其佑（自二零二三年八月二十二日起 獲委任）獨立非執行董事黃嘉慧林絢琛（自二零二四年一月十八日起辭任）劉德基林��（自二零二四年四月十七日起獲委任）監察主任吳志龍授權代表吳志龍鄭鋼（自二零二三年八月二十二日起辭任）林全智（自二零二三年八月二十二日起 獲委任）公司秘書林全智executive directorsng chi lung (chairman)zheng gang (resigned with effect from 22 august 2023)wu qiyou (appointed with effect from 22 august 2023)independent non-executive directorswong ka wai, jeannelam huen sum (resigned with effect from 18 january 2024)lau tak kei arthurlin yaomin (appointed with effect from 17 april 2024)compliance officerng chi lungauthorised representativesng chi lungzheng gang (resigned with effect from 22 august 2023)lam williamson (appointed with effect from 22 august 2023)company secretarylam williamsoncorporate information公司資料 good fellow healthcare holdings limited annual report 2023/20244corporate information公司資料 audit committeewong ka wai, jeanne (chairlady)lam huen sum (resigned with effect from 18 january 2024)lau tak kei arthurlin yaomin (appointed with ef